Compare CMRC & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMRC | FOCL |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | France |
| Employees | 1079 | 289 |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.1M | 203.7M |
| IPO Year | N/A | N/A |
| Metric | CMRC | FOCL |
|---|---|---|
| Price | $2.71 | $6.03 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.88 | N/A |
| AVG Volume (30 Days) | ★ 589.9K | 43.1K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.11 | N/A |
| Revenue Next Year | $4.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.41 | $4.76 |
| 52 Week High | $5.55 | $6.18 |
| Indicator | CMRC | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 85.41 |
| Support Level | $2.51 | $5.30 |
| Resistance Level | $3.13 | N/A |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 13.91 | 82.83 |
Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.